Cargando…

Multiple myeloma in Korea: risk stratification and initial treatment

Detalles Bibliográficos
Autor principal:	Yoon, Sung-Soo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2018
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6170304/ https://www.ncbi.nlm.nih.gov/pubmed/30310779 http://dx.doi.org/10.5045/br.2018.53.3.183

Ejemplares similares

Optimizing carfilzomib use in multiple myeloma treatment
por: Yoon, Sung-Soo
Publicado: (2019)

Perspectives on the Risk-Stratified Treatment of Multiple Myeloma
por: Davies, Faith E., et al.
Publicado: (2022)

Risk Stratification and Treatment in Smoldering Multiple Myeloma
por: Lussier, Tyler, et al.
Publicado: (2021)

Multiple Myeloma: Risk Stratification and Toxicity Management
por: Richards, Tiffany, et al.
Publicado: (2018)

Genetic Markers Used for Risk Stratification in Multiple Myeloma
por: Segges, Priscilla, et al.
Publicado: (2011)

Risk Stratification in Multiple Myeloma: Putting the Pieces Together
por: Mayo, Angela, et al.
Publicado: (2016)

On Risk Estimation versus Risk Stratification in Early Prostate Cancer
por: Carlsson, Sigrid V., et al.
Publicado: (2016)

Steps towards a Multiple Myeloma Cure?
por: Gozzetti, Alessandro, et al.
Publicado: (2022)

Major advances in the treatment of multiple myeloma in American Society of Hematology annual meeting 2020
por: Du, Jianhua, et al.
Publicado: (2021)

International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM)
por: Mateos, María-Victoria, et al.
Publicado: (2020)

Plerixafor use for peripheral blood stem cell mobilization in Korea
por: Kim, Seok Jin, et al.
Publicado: (2013)

SARS-CoV-2 Vaccines in Patients With Multiple Myeloma
por: Gavriatopoulou, Maria, et al.
Publicado: (2021)

Centrosome associated genes pattern for risk sub-stratification in multiple myeloma
por: Kryukov, Fedor, et al.
Publicado: (2016)

Clinical Features and Risk Stratification of Multiple Myeloma Patients with COVID-19
por: Zheng, Ruifang, et al.
Publicado: (2023)

Genomic Stratification of Hematological Malignancies
por: Robbe, Pauline, et al.
Publicado: (2023)

Response to “The Role of FcRn in the Pharmacokinetics of Biologics in Patients with Multiple Myeloma”
por: Xu, Xu Steven, et al.
Publicado: (2017)

ImmunoPET in Multiple Myeloma—What? So What? Now What?
por: Bailly, Clément, et al.
Publicado: (2020)

The Immune Microenvironment in Multiple Myeloma Progression at a Single-cell Level
por: Schinke, Carolina, et al.
Publicado: (2023)

T-cell redirecting bispecific antibodies targeting BCMA for the treatment of multiple myeloma
por: Verkleij, Christie P.M., et al.
Publicado: (2020)

Benefits of patient risk stratification and targeted interventions on multidrug resistant pathogens prevention and control
por: Russo, Emanuele, et al.
Publicado: (2022)

Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteria
por: Lakshman, Arjun, et al.
Publicado: (2018)

The RAG Model: A New Paradigm for Genetic Risk Stratification in Multiple Myeloma
por: Prideaux, Steven M., et al.
Publicado: (2014)

Development and validation of a novel risk stratification algorithm for relapsed multiple myeloma
por: Hájek, Roman, et al.
Publicado: (2019)

Use of lenalidomide in the management of relapsed or refractory multiple myeloma: expert recommendations in Korea
por: Kim, Hyo Jung, et al.
Publicado: (2015)

Unsupervised machine learning improves risk stratification in newly diagnosed multiple myeloma: an analysis of the Spanish Myeloma Group
por: Mosquera Orgueira, Adrian, et al.
Publicado: (2022)

The high cost burden of third- to fifth-line treatments for multiple myeloma: unsustainable and unaffordable
por: Jensen, Chelsee
Publicado: (2021)

Understanding the Mechanisms of Resistance to T Cell-based Immunotherapies to Develop More Favorable Strategies in Multiple Myeloma
por: Ahn, Sungwoo, et al.
Publicado: (2021)

Biological Characterization and Clinical Relevance of Circulating Tumor Cells: Opening the Pandora’s Box of Multiple Myeloma
por: Garcés, Juan-José, et al.
Publicado: (2022)

Methodology of a Novel Risk Stratification Algorithm for Patients with Multiple Myeloma in the Relapsed Setting
por: Bouwmeester, Walter, et al.
Publicado: (2019)

P02: PROGNOSTIC STRATIFICATION OF STANDARD RISK MULTIPLE MYELOMA DEFINED BY REVISED ISS
por: Barilà, G, et al.
Publicado: (2022)

Clonal heterogeneity by fluorescence in situ hybridization in multiple myeloma: enhanced cytogenetic risk stratification
por: Abdel-Qader, Hadeel Yaseen, et al.
Publicado: (2022)

Artificial intelligence for precision oncology: beyond patient stratification
por: Azuaje, Francisco
Publicado: (2019)

Multiple Myeloma as a Bone Disease? The Tissue Disruption-Induced Cell Stochasticity (TiDiS) Theory
por: Capp, Jean-Pascal, et al.
Publicado: (2020)

Treatment patterns and outcomes according to cytogenetic risk stratification in patients with multiple myeloma: a real-world analysis
por: Atrash, Shebli, et al.
Publicado: (2022)

Myeloma Bone Disease
por: Sanderson, Ralph D, et al.
Publicado: (2009)

Insight into Classification and Risk Stratification of Head and Neck Squamous Cell Carcinoma in Era of Emerging Biomarkers with Focus on Histopathologic Parameters
por: Mäkitie, Antti A., et al.
Publicado: (2022)

A critical role for the NFkB pathway in multiple myeloma
por: Demchenko, Yulia N., et al.
Publicado: (2010)

Developing next generation immunomodulatory drugs and their combinations in multiple myeloma
por: Thakurta, Anjan, et al.
Publicado: (2021)

Treatment of elderly patients with refractory/relapsed multiple myeloma: oral drugs adherence and the COVID-19 outbreak
por: Xavier, Flávia Dias, et al.
Publicado: (2020)

Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement
por: Gonsalves, Wilson I., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_604lnnt3p7o1un43bs0id20p1v